SEC Form 4 · accession 0001171843-16-013706
Xenon Pharmaceuticals Inc. · XENE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank A Holler
Director
Period of report
Dec 15, 2016
Accepted (ET)
Dec 19, 2016 · 5:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001582313
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Dec 15, 2016 | S | 30,000 | $7.85 | D | 115,869 | D | |
| Common Shares | holding | — | — | — | 1,184 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.